Coltac Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 3

Coltac Therapeutics General Information

Description

Developer of a proprietary high-throughput screening system designed to discover novel molecular glues for protein degradation to aid in cancer treatment. The company offers a multimodal, iterative approach that combines deep structural biology expertise with computational methods, enabling researchers and pharmaceutical companies to identify specific Ubiquitin ligases (E3s) libraries for targeted drug development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Raanana 4350108
  • Israel
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Raanana 4350108
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coltac Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Apr-2022 Completed Startup
1. University Spin-Out 01-Jan-2021 Completed Startup
To view Coltac Therapeutics’s complete valuation and funding history, request access »

Coltac Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Coltac Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
aMoon Fund Venture Capital Minority
Israel Biotech Fund Venture Capital Minority
Ramot at Tel Aviv University University Minority
To view Coltac Therapeutics’s complete investors history, request access »

Coltac Therapeutics FAQs

  • When was Coltac Therapeutics founded?

    Coltac Therapeutics was founded in 2021.

  • Where is Coltac Therapeutics headquartered?

    Coltac Therapeutics is headquartered in Raanana, Israel.

  • What is the size of Coltac Therapeutics?

    Coltac Therapeutics has 10 total employees.

  • What industry is Coltac Therapeutics in?

    Coltac Therapeutics’s primary industry is Drug Discovery.

  • Is Coltac Therapeutics a private or public company?

    Coltac Therapeutics is a Private company.

  • What is Coltac Therapeutics’s current revenue?

    The current revenue for Coltac Therapeutics is .

  • Who are Coltac Therapeutics’s investors?

    aMoon Fund, Israel Biotech Fund, and Ramot at Tel Aviv University have invested in Coltac Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process